Statistics in Biopharmaceutical Research

Papers
(The H4-Index of Statistics in Biopharmaceutical Research is 11. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-02-01 to 2025-02-01.)
ArticleCitations
Rejoinder to Commentaries on “Estimands for Recurrent Event Endpoints in the Presence of a Terminal Event”34
A Closer Look at the Kernels Generated by the Decision and Regression Tree Ensembles31
Good Data Science Practice: Moving toward a Code of Practice for Drug Development (Rejoinder)25
Editor’s Note: Special Section on a Collection of Articles on Opportunities and Challenges in Utilizing Real-World Data for Clinical Trials and Medical Product Development21
Multiarmed Bandit Designs for Phase I Dose-Finding Clinical Trials With Multiple Toxicity Types16
Combined Tests Based on Restricted Mean Time Lost for Competing Risks Data15
Eliciting the Discount Parameter in a Power Prior Method on the Basis of the Type I Error Consideration14
Similarity-Principle-Based Machine Learning Method for Clinical Trials and Beyond14
Use of Nonconcurrent Common Control in Master Protocols in Oncology Trials: Report of an American Statistical Association Biopharmaceutical Section Open Forum Discussion14
U-MET: Utility-Based Dose Optimization Approach for Multiple-Dose Randomized Trial Designs13
Composite Endpoints in Cardio-Renal Clinical Outcome Trials12
On Variance Estimation for the One-Sample Log-Rank Test11
Estimands for Continuous Longitudinal Outcomes in the Presence of Treatment Discontinuation—A Simulation Study in Hyperkalemia Treatments11
0.054812908172607